The pilot laboratory study revealed that urine caspase-cleaved cytokeratin-18 epitope M30 indicative of renal tubular cell apoptosis could be a potential early biomarker of AKI among patients without severe sepsis. The gene discussed is KRT18; the disease is acute kidney injury.